ESC Professional Premium Access

Correlation of lipoprotein (a) with parameters of lipid profile and other cardiovascular risk factors in patients with familial combined hyperlipidemia

Congress Presentation

About the speaker

Doctor Ioannis Andrikou

Hippokration General Hospital, Athens (Greece)
1 presentation
0 follower

5 more presentations in this session

Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab

Speaker: Doctor T. Michaeli (Mannheim, DE) Mr D. Michaeli (Mannheim, DE)

Thumbnail

Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

Speaker: Doctor R. Rosenson (New York, US)

Thumbnail

Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients

Speaker: Doctor A. Bilitou (Munich, DE)

Thumbnail

PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study

Speaker: Doctor C. Basile (Naples, IT)

Thumbnail

Worldwide comparative efficacy of nutraceuticals on lipid profile. an updated systematic review and network meta-analysis

Speaker: Doctor T. Osadnik (Zabrze, PL)

Thumbnail

Access the full session

Lipids - Drug therapy 1

Speakers: Doctor I. Andrikou, Doctor T. Michaeli, Mr D. Michaeli, Doctor R. Rosenson, Doctor A. Bilitou...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk